These tumors exhibited a unique serum tumor marker expression pattern (low CEA, high CYFRA), reduced vascular invasion, a higher rate of complete surgical resection, and better disease control in pathological stage I compared to the HGNEC-non-dominant group. The gene discussed is CEACAM5; the disease is neoplasm.